Covid Variant Vaccination
The Covid-19 pandemic has brought the world to a standstill. A new strand of the virus, known as the Covid-19 variant, has emerged causing more concern among health experts globally. The emergence of Covid-19 variant is a testament to the virus's ability to evolve and adapt to its environment. The new variant has raised concerns that the existing vaccines may not be as effective as they need to be. The progress of Covid-19 vaccination worldwide has been a significant relief, particularly among the vulnerable portion of the population. However, governments worldwide are grappling with the vaccination plans to combat the new Covid-19 variant. Experts have called for swift actions to boost the availability of the Covid-19 variant vaccine. Several pharmaceutical firms have now shifted their focus to develop vaccines to target the new Covid-19 variant. The Pfizer vaccine and the Moderna vaccine have both been confirmed to be effective against the new strand, given time for sufficient booster shots. Vaccines offer an opportunity to reduce the spread of the Covid-19 variant and end the pandemic. Different experiences and research show that the virus is more infectious than the earlier variants. However, the power of the vaccine could help prevent people from getting infected, reduce the severity of the disease, and prevent fatalities. In conclusion, while vaccination has offered hope to end the pandemic, the emergence of the new Covid-19 variant has necessitated the need for new vaccines. Governments should work together globally to prioritize the development and distribution of vaccines to protect individuals, particularly the vulnerable population. In the meantime, we should all adhere to the WHO guidelines and protocols to curb the spread.
←